Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003418846 | SCV004115603 | likely pathogenic | CEP104-related disorder | 2022-12-30 | criteria provided, single submitter | clinical testing | The CEP104 c.895C>T variant is predicted to result in premature protein termination (p.Arg299*). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0026% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-3754080-G-A). Nonsense variants in CEP104 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |
Fulgent Genetics, |
RCV005030023 | SCV005654335 | likely pathogenic | Joubert syndrome 25; Intellectual developmental disorder, autosomal recessive 77 | 2024-02-29 | criteria provided, single submitter | clinical testing |